November 28, 2014 5:42 PM ET

Life Sciences Tools and Services

Company Overview of Inpharmatica Ltd.

Executive Profile

Mike Tarbit Ph.D.

Senior Vice President of Preclinical R&D, Inpharmatica Ltd.
AgeTotal Calculated CompensationThis person is connected to 2 Board Members in 2 different organizations across 3 different industries.

See Board Relationships
----

Background

Dr. Mike Tarbit, Ph.D. serves as a Pre-Clinical and Clinical Advisor at Cellzome AG. Dr. Tarbit served as a Senior Vice President of Preclinical R&D of Inpharmatica Ltd. Dr. Tarbit joined Inpharmatica in April 2003. He is an Independent Consultant. He served as Managing Director of Camitro/Arqule, a company developing predictive ADME technology and lead optimization. Dr. Tarbit formed the UK subsidiary in 2001, after leaving Glaxo Wellcome, where he served as Director ...

Corporate Headquarters

1 New Oxford Street
London, Greater London WC1A 1NU

United Kingdom

Phone: 44 20 7074 4600
Fax: 44 20 7074 4700

Board Members Memberships

There is no Board Members Memberships data available.

Education

There is no Education data available.

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Inpharmatica Ltd., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.